Japan · Delayed Price · Currency is JPY PeptiDream Statistics
Total Valuation
PeptiDream has a market cap or net worth of JPY 136.35 billion. The enterprise value is 128.43 billion.
| Market Cap | 136.35B |
| Enterprise Value | 128.43B |
Important Dates
The next confirmed earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PeptiDream has 128.57 million shares outstanding. The number of shares has decreased by -0.36% in one year.
| Current Share Class | 128.57M |
| Shares Outstanding | 128.57M |
| Shares Change (YoY) | -0.36% |
| Shares Change (QoQ) | -0.51% |
| Owned by Insiders (%) | 25.66% |
| Owned by Institutions (%) | 42.32% |
| Float | 95.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 16.97 |
| PS Ratio | 7.10 |
| PB Ratio | 2.81 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.15, with a Debt / Equity ratio of 0.32.
| Current Ratio | 4.15 |
| Quick Ratio | 3.53 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.91 |
| Interest Coverage | -19.24 |
Financial Efficiency
Return on equity (ROE) is -7.09% and return on invested capital (ROIC) is -11.99%.
| Return on Equity (ROE) | -7.09% |
| Return on Assets (ROA) | -4.04% |
| Return on Invested Capital (ROIC) | -11.99% |
| Return on Capital Employed (ROCE) | -7.58% |
| Weighted Average Cost of Capital (WACC) | 4.82% |
| Revenue Per Employee | 25.17M |
| Profits Per Employee | -4.75M |
| Employee Count | 763 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 3.23 |
Taxes
| Income Tax | -1.48B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.24% in the last 52 weeks. The beta is 0.18, so PeptiDream's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -40.24% |
| 50-Day Moving Average | 1,025.97 |
| 200-Day Moving Average | 1,271.34 |
| Relative Strength Index (RSI) | 44.16 |
| Average Volume (20 Days) | 806,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PeptiDream had revenue of JPY 19.20 billion and -3.63 billion in losses. Loss per share was -28.10.
| Revenue | 19.20B |
| Gross Profit | 8.32B |
| Operating Income | -4.87B |
| Pretax Income | -5.11B |
| Net Income | -3.63B |
| EBITDA | -2.82B |
| EBIT | -4.87B |
| Loss Per Share | -28.10 |
Balance Sheet
The company has 23.60 billion in cash and 15.69 billion in debt, with a net cash position of 7.91 billion or 61.56 per share.
| Cash & Cash Equivalents | 23.60B |
| Total Debt | 15.69B |
| Net Cash | 7.91B |
| Net Cash Per Share | 61.56 |
| Equity (Book Value) | 48.56B |
| Book Value Per Share | 377.66 |
| Working Capital | 25.10B |
Cash Flow
In the last 12 months, operating cash flow was -4.14 billion and capital expenditures -1.25 billion, giving a free cash flow of -5.39 billion.
| Operating Cash Flow | -4.14B |
| Capital Expenditures | -1.25B |
| Depreciation & Amortization | 2.05B |
| Net Borrowing | -2.64B |
| Free Cash Flow | -5.39B |
| FCF Per Share | -41.94 |
Margins
Gross margin is 43.35%, with operating and profit margins of -25.35% and -18.88%.
| Gross Margin | 43.35% |
| Operating Margin | -25.35% |
| Pretax Margin | -26.60% |
| Profit Margin | -18.88% |
| EBITDA Margin | -14.68% |
| EBIT Margin | -25.35% |
| FCF Margin | n/a |
Dividends & Yields
PeptiDream does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.36% |
| Shareholder Yield | 0.36% |
| Earnings Yield | -2.66% |
| FCF Yield | -3.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for PeptiDream is 2,608.33, which is 151.65% higher than the current price. The consensus rating is "Buy".
| Price Target | 2,608.33 |
| Price Target Difference | 151.65% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 34.16% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on June 28, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Jun 28, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
PeptiDream has an Altman Z-Score of 6.08 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.08 |
| Piotroski F-Score | 3 |